Unicorn Nest Logo

MBX Capital

mbxcapital.com
Type

Venture Capital

Status

Active

Location

Claymont, United States

Total investments

32

Average round size

13M

Portfolio companies

27

Lead investments

2

Follow on index

0.16

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyDrug DiscoveryPharmaceuticalsHealth CareWellnessMedical DeviceMedicalLife ScienceTherapeuticsDental

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistHealthcareMedtechConsumer/Retail
Stage focus
Series ASeed
Geo focus
CanadaUnited States
Check size
250K — 6M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments
32
Lead investments
2
Follow on index
0.16
Investments by industry
  • Health Care (22)
  • Biotechnology (15)
  • Medical (6)
  • Medical Device (4)
  • Life Science (4)
    • Show 34 more
Investments by region
  • United States (30)
  • India (1)
  • Canada (1)
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
67M
Group Appearance index
0.84

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
SmileMD 13 Apr 2022 Health Care, Medical, Dental Early Stage Venture 9M United States, Ohio, Dublin
Vivodyne 22 Nov 2023 Biotechnology, Medical, Lifestyle Seed 38M United States, Pennsylvania, Philadelphia
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.